← back to search

Sonia Maciejewski

Global Viral · US
Area of research
Infectious Diseases · Cardiology and Cardiovascular Medicine
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Viral Infections and Immunology Research, and Mosquito-borne diseases and control.
h-index
17
citations
1,590
works
33
NIH funding
—
primary concept
Biology
email
smaciejewski@novavavax.com

Recent publications

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Nature Communications 2021cited by 524position: middledoi
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Cell Reports Medicine 2021cited by 146position: middledoi
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Vaccine 2020cited by 241position: middledoi
Modification of picornavirus genomic RNA using ‘click’ chemistry shows that unlinking of the VPg peptide is dispensable for translation and replication of the incoming viral RNA
Nucleic Acids Research 2013cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Floris L. van Delft · Utrecht University1 papers (2013–2013)Pedro A. Piedra · Baylor University1 papers (2020–2020)Richard Virgen‐Slane · Utrecht University1 papers (2013–2013)— · 1 papers (2020–2020)Bert L. Semler · Utrecht University1 papers (2013–2013)Gerbrand J. van der Heden van Noort · Leiden University Medical Center1 papers (2013–2013)Dmitri V. Filippov · Utrecht University1 papers (2013–2013)Feng Qian · University of Maryland, Baltimore1 papers (2013–2013)Nita Patel · Foundation for Ichthyosis and Related Skin Types1 papers (2020–2020)Gale Smith · Novavax (United States)1 papers (2020–2020)— · 1 papers (2020–2020)Frank H. T. Nelissen · Utrecht University1 papers (2013–2013)— · 1 papers (2020–2020)Alyse D. Portnoff · Novavax (United States)1 papers (2020–2020)— · 1 papers (2020–2020)— · 1 papers (2020–2020)Martijn A. Langereis · Utrecht University1 papers (2013–2013)Gregory M. Glenn · Novavax (United States)1 papers (2020–2020)Matthew B. Frieman · University of Mary1 papers (2020–2020)Bin Zhou · State Key Laboratory of Medical Neurobiology1 papers (2020–2020)